골육종 시장 규모는 향후 수년간 강력한 성장이 예상될 예정입니다. 비율의 상승, 면역요법에 의한 치료 성적 개선의 가능성 등에 기인한다고 생각됩니다. 이 기간에 예상되는 주요 동향에는 표적 요법의 개발, 면역 요법의 발전, 맞춤형 의료의 채용, 유전자 편집 기술의 진보, 화학 요법약의 혁신, 화상 진단 기술의 향상, 수술 기술의 진보 등이 있습니다.
암의 유병률 증가는 향후 몇 년간의 골육종 시장의 확대를 촉진할 것으로 예측됩니다. 환경 노출, 감염, 유전적 소인 등, 여러 요인이 암 발생률 상승에 기여하고 있습니다. 이러한 발전은 더 나은 환자 치료, 생존율 향상, 그리고 더 효과적인 치료법의 개발로 이어집니다. 2040년까지 연간 2,990만 명의 신규 암 환자와 1,530만 명의 사망자로 증가할 가능성이 있습니다.
골육종 시장의 주요 기업은 치료 효과를 높이고 부작용을 최소화하고 환자의 생존 결과를 개선하기 위해 희귀 질병 의약품(오판 약물)에 지정된 선진 의약품 개발을 우선하고 있습니다. 희소질환용 의약품의 지정은 희소질환을 치료하도록 설계된 의약품 또는 생물제제에 규제당국이 부여한 특별한 상태이며, 세제우대조치, 임상검사지원, 시장독점권 연장 등 이점을 설명합니다. 예를 들어, 미국 제약 회사 리서터 세라퓰틱스는 2024년 4월 회사의 연구 약물 LSTA1이 미국 식품 의약국(FDA)으로부터 희귀 질병 의약품 지정을 받았습니다. LSTA1은 새로운 섭취 경로를 활성화하고 골육종 종양에 대한 약물의 침투와 축적을 향상시키는 동시에 종양 미세 환경을 변경하여 면역 요법에 대한 반응성을 향상시킬 수 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 골육종 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업의 분석
- 세계의 골육종 시장 : 성장률 분석
- 세계의 골육종 시장 실적 : 규모와 성장, 2019-2024년
- 세계의 골육종 시장 예측 : 규모와 성장, 2024-2029년, 2034년
- 세계의 골육종 전체 시장 규모(TAM)
제6장 시장 세분화
- 세계의 골육종 시장 : 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 수내골육종
- 피질 근방 골육종
- 골격외 골육종
- 세계의 골육종 시장 : 치료 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 수술
- 화학요법
- 방사선치료
- 표적요법
- 면역요법
- 세계의 골육종 시장 : 연령층별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 소아
- 성인
- 세계의 골육종 시장 : 유통 채널별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 온라인 채널
- 오프라인 채널
- 세계의 골육종 시장 : 최종사용자별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 병원 및 클리닉
- 진단센터
- 학술연구기관
- 세계의 골육종 시장 : 수내 골육종의별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 골간단부 골육종
- 골간골육종
- 세계의 골육종 시장 : 피질 근방 골육종별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 파로스티알 골육종
- 골막골육종
- 세계의 골육종 시장 : 골외성 골육종별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 1차 골격외 골육종
- 2차 골격외 골육종
제7장 지역별/국가별 분석
- 세계의 골육종 시장 :지역별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 세계의 골육종 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
- 골육종 시장 : 경쟁 구도
- 골육종 시장 : 기업 프로파일
- Pfizer Inc.
- Johnson & Johnson
- Merck & Co. Inc.
- AbbVie Inc.
- Bayer AG
제31장 기타 주요 기업 및 혁신 기업
- Sanofi SA
- Bristol-Myers Squibb Company
- Novartis AG
- AstraZeneca PLC
- GSK plc
- Takeda Pharmaceutical Company Limited
- Eli Lilly and Company
- Amgen Inc.
- Baxter International Inc.
- Hikma Pharmaceuticals PLC
- Spectrum Pharmaceuticals Inc.
- Mylan NV
- Bellicum Phamaceuticals Inc.
- ADVAXIS Inc.
- Iovance BIoTherapeutics Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 전략
- 골육종 시장, 2029년 : 새로운 기회를 제공하는 국가
- 골육종 시장, 2029년 : 새로운 기회를 제공하는 부문
- 골육종 시장, 2029년 : 성장 전략
제36장 부록
SHW
Osteosarcoma is a malignant tumor that develops in bone-forming cells, primarily affecting the long bones of the body. It most commonly impacts teenagers and young adults, causing symptoms such as pain, swelling, and difficulty in movement.
The primary types of osteosarcoma include intramedullary osteosarcoma, juxtacortical osteosarcoma, and extraskeletal osteosarcoma. Intramedullary osteosarcoma, the most common form, affects long bones such as the arms and legs. Originating in the bone marrow, it grows and spreads rapidly, often leading to fractures or swelling, particularly in teenagers and young adults. Treatment options include surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy. It is used for both pediatric and adult patients and is distributed through online and offline channels. The disease is managed in various settings, including hospitals and clinics, diagnostic centers, and academic and research institutions.
The osteosarcoma market research report is one of a series of new reports from The Business Research Company that provides osteosarcoma market statistics, including the osteosarcoma industry's global market size, regional shares, competitors with an osteosarcoma market share, detailed osteosarcoma market segments, market trends and opportunities, and any further data you may need to thrive in the osteosarcoma industry. This osteosarcoma market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The osteosarcoma market size has grown strongly in recent years. It will grow from $0.71 billion in 2024 to $0.76 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth during the historic period can be attributed to increasing cancer awareness, improved treatment options, a rise in bone cancer incidence, advancements in healthcare infrastructure, growth in research and clinical trials, and the development of targeted therapies and immunotherapies.
The osteosarcoma market size is expected to see strong growth in the next few years. It will grow to $0.99 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to the rising adoption of personalized medicine, increasing awareness of rare cancers, growing government and private sector funding for research, a rising incidence of genetic mutations, and the potential for improved treatment outcomes with immunotherapy. Key trends expected during this period include the development of targeted therapies, advancements in immunotherapies, the adoption of personalized medicine, progress in gene editing techniques, innovation in chemotherapy drugs, improvements in diagnostic imaging technologies, and advancements in surgical techniques.
The increasing prevalence of cancer is expected to drive the expansion of the osteosarcoma market in the coming years. Cancer is a disease marked by the uncontrolled growth and spread of abnormal cells, which can invade and damage healthy tissues. Several factors contribute to the rising incidence of cancer, including an aging population, lifestyle changes, environmental exposures, infections, and genetic predisposition. Osteosarcoma treatment plays a crucial role in advancing therapeutic strategies, improving early detection techniques, and deepening the understanding of bone cancer. These developments lead to better patient care, improved survival rates, and the creation of more effective therapies. For example, in May 2024, the National Cancer Institute, a US-based government agency, reported that in 2022, approximately 20 million new cancer cases and 9.7 million cancer-related deaths were recorded worldwide. Projections indicate that these numbers could increase to 29.9 million new cases and 15.3 million deaths annually by 2040. Consequently, the rising prevalence of cancer is fueling the growth of the osteosarcoma market.
Major companies in the osteosarcoma market are prioritizing the development of advanced drugs with orphan drug designation to enhance treatment effectiveness, minimize side effects, and improve survival outcomes for patients. Orphan drug designation is a special status granted by regulatory agencies to drugs or biologics designed to treat rare diseases, offering benefits such as tax incentives, clinical trial support, and extended market exclusivity. For instance, in April 2024, Lisata Therapeutics Inc., a US-based pharmaceutical company, announced that its investigational drug LSTA1 received orphan drug designation from the US Food and Drug Administration (FDA). LSTA1 is designed to activate a novel uptake pathway, enhancing drug penetration and accumulation in osteosarcoma tumors while potentially modifying the tumor microenvironment to improve responsiveness to immunotherapies.
In May 2024, Telix Pharmaceuticals Limited, an Australia-based biotechnology company, acquired QSAM Biosciences Inc. for an undisclosed amount. This acquisition is intended to expand Telix Pharmaceuticals' oncology portfolio, reinforce its expertise in targeted cancer therapies, and strengthen its capabilities in rare disease treatments, particularly osteosarcoma. QSAM Biosciences Inc. is a US-based company specializing in osteosarcoma drug development.
Major players in the osteosarcoma market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Novartis AG, AstraZeneca PLC, GSK plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Baxter International Inc., Hikma Pharmaceuticals PLC, Spectrum Pharmaceuticals Inc., Mylan N.V., Bellicum Phamaceuticals Inc., ADVAXIS Inc., Iovance Biotherapeutics Inc.
North America was the largest region in the osteosarcoma market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in osteosarcoma report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the osteosarcoma market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The osteosarcoma market consists of revenues earned by entities by providing services such as diagnostic services, and supportive care solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The osteosarcoma market also includes sales of methotrexate, doxorubicin, prosthetic implants, and immune checkpoint inhibitors. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Osteosarcoma Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on osteosarcoma market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for osteosarcoma ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The osteosarcoma market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Intramedullary Osteosarcoma; Juxtacortical Osteosarcoma; Extraskeletal Osteosarcoma
- 2) By Treatment Type: Surgery; Chemotherapy; Radiation Therapy; Targeted Therapy; Immunotherapy
- 3) By Age Group: Pediatric; Adult
- 4) By Distribution Channel: Online Channel; Offline Channel
- 5) By End User: Hospitals And Clinics; Diagnostic Centers; Academic And Research Organizations
- Subsegments:
- 1) By Intramedullary Osteosarcoma: Metaphyseal Osteosarcoma; Diaphyseal Osteosarcoma
- 2) By Juxtacortical Osteosarcoma: Parosteal Osteosarcoma; Periosteal Osteosarcoma
- 3) By Extraskeletal Osteosarcoma: Primary Extraskeletal Osteosarcoma; Secondary Extraskeletal Osteosarcoma
- Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co. Inc.; AbbVie Inc.; Bayer AG
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Osteosarcoma Market Characteristics
3. Osteosarcoma Market Trends And Strategies
4. Osteosarcoma Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Osteosarcoma Growth Analysis And Strategic Analysis Framework
- 5.1. Global Osteosarcoma PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Osteosarcoma Market Growth Rate Analysis
- 5.4. Global Osteosarcoma Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Osteosarcoma Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Osteosarcoma Total Addressable Market (TAM)
6. Osteosarcoma Market Segmentation
- 6.1. Global Osteosarcoma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Intramedullary Osteosarcoma
- Juxtacortical Osteosarcoma
- Extraskeletal Osteosarcoma
- 6.2. Global Osteosarcoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Surgery
- Chemotherapy
- Radiation Therapy
- Targeted Therapy
- Immunotherapy
- 6.3. Global Osteosarcoma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Pediatric
- Adult
- 6.4. Global Osteosarcoma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Online Channel
- Offline Channel
- 6.5. Global Osteosarcoma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals And Clinics
- Diagnostic Centers
- Academic And Research Organizations
- 6.6. Global Osteosarcoma Market, Sub-Segmentation Of Intramedullary Osteosarcoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Metaphyseal Osteosarcoma
- Diaphyseal Osteosarcoma
- 6.7. Global Osteosarcoma Market, Sub-Segmentation Of Juxtacortical Osteosarcoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Parosteal Osteosarcoma
- Periosteal Osteosarcoma
- 6.8. Global Osteosarcoma Market, Sub-Segmentation Of Extraskeletal Osteosarcoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Primary Extraskeletal Osteosarcoma
- Secondary Extraskeletal Osteosarcoma
7. Osteosarcoma Market Regional And Country Analysis
- 7.1. Global Osteosarcoma Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Osteosarcoma Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Osteosarcoma Market
- 8.1. Asia-Pacific Osteosarcoma Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Osteosarcoma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Osteosarcoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Osteosarcoma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Osteosarcoma Market
- 9.1. China Osteosarcoma Market Overview
- 9.2. China Osteosarcoma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Osteosarcoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Osteosarcoma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Osteosarcoma Market
- 10.1. India Osteosarcoma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Osteosarcoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Osteosarcoma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Osteosarcoma Market
- 11.1. Japan Osteosarcoma Market Overview
- 11.2. Japan Osteosarcoma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Osteosarcoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Osteosarcoma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Osteosarcoma Market
- 12.1. Australia Osteosarcoma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Osteosarcoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Osteosarcoma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Osteosarcoma Market
- 13.1. Indonesia Osteosarcoma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Osteosarcoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Osteosarcoma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Osteosarcoma Market
- 14.1. South Korea Osteosarcoma Market Overview
- 14.2. South Korea Osteosarcoma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Osteosarcoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Osteosarcoma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Osteosarcoma Market
- 15.1. Western Europe Osteosarcoma Market Overview
- 15.2. Western Europe Osteosarcoma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Osteosarcoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Osteosarcoma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Osteosarcoma Market
- 16.1. UK Osteosarcoma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Osteosarcoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Osteosarcoma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Osteosarcoma Market
- 17.1. Germany Osteosarcoma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Osteosarcoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Osteosarcoma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Osteosarcoma Market
- 18.1. France Osteosarcoma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Osteosarcoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Osteosarcoma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Osteosarcoma Market
- 19.1. Italy Osteosarcoma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Osteosarcoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Osteosarcoma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Osteosarcoma Market
- 20.1. Spain Osteosarcoma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Osteosarcoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Osteosarcoma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Osteosarcoma Market
- 21.1. Eastern Europe Osteosarcoma Market Overview
- 21.2. Eastern Europe Osteosarcoma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Osteosarcoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Osteosarcoma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Osteosarcoma Market
- 22.1. Russia Osteosarcoma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Osteosarcoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Osteosarcoma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Osteosarcoma Market
- 23.1. North America Osteosarcoma Market Overview
- 23.2. North America Osteosarcoma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Osteosarcoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Osteosarcoma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Osteosarcoma Market
- 24.1. USA Osteosarcoma Market Overview
- 24.2. USA Osteosarcoma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Osteosarcoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Osteosarcoma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Osteosarcoma Market
- 25.1. Canada Osteosarcoma Market Overview
- 25.2. Canada Osteosarcoma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Osteosarcoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Osteosarcoma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Osteosarcoma Market
- 26.1. South America Osteosarcoma Market Overview
- 26.2. South America Osteosarcoma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Osteosarcoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Osteosarcoma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Osteosarcoma Market
- 27.1. Brazil Osteosarcoma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Osteosarcoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Osteosarcoma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Osteosarcoma Market
- 28.1. Middle East Osteosarcoma Market Overview
- 28.2. Middle East Osteosarcoma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Osteosarcoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Osteosarcoma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Osteosarcoma Market
- 29.1. Africa Osteosarcoma Market Overview
- 29.2. Africa Osteosarcoma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Osteosarcoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Osteosarcoma Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Osteosarcoma Market Competitive Landscape And Company Profiles
- 30.1. Osteosarcoma Market Competitive Landscape
- 30.2. Osteosarcoma Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
31. Osteosarcoma Market Other Major And Innovative Companies
- 31.1. Sanofi S.A.
- 31.2. Bristol-Myers Squibb Company
- 31.3. Novartis AG
- 31.4. AstraZeneca PLC
- 31.5. GSK plc
- 31.6. Takeda Pharmaceutical Company Limited
- 31.7. Eli Lilly and Company
- 31.8. Amgen Inc.
- 31.9. Baxter International Inc.
- 31.10. Hikma Pharmaceuticals PLC
- 31.11. Spectrum Pharmaceuticals Inc.
- 31.12. Mylan N.V.
- 31.13. Bellicum Phamaceuticals Inc.
- 31.14. ADVAXIS Inc.
- 31.15. Iovance Biotherapeutics Inc.
32. Global Osteosarcoma Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Osteosarcoma Market
34. Recent Developments In The Osteosarcoma Market
35. Osteosarcoma Market High Potential Countries, Segments and Strategies
- 35.1 Osteosarcoma Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Osteosarcoma Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Osteosarcoma Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
